Home/Filings/4/0001209191-22-016200
4//SEC Filing

Pierce Valerie L 4

Accession 0001209191-22-016200

CIK 0001426332other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:08 PM ET

Size

5.4 KB

Accession

0001209191-22-016200

Insider Transaction Report

Form 4
Period: 2022-03-03
Pierce Valerie L
SVP, GC & CCO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-03-03+150,000150,000 total
    Exercise: $15.20Exp: 2032-03-02Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001397112

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:08 PM ET
Size
5.4 KB